Pharmaceuticals Delivery in Ireland. Getting a Bigger Bang for the Buck
No abstract is available for this item.
|This book is provided by Economic and Social Research Institute (ESRI) in its series Research Series with number RS24 and published in 2012.|
|Contact details of provider:|| Postal: Whitaker Square, Sir John Rogerson's Quay, Dublin 2|
Phone: (353-1) 863 2000
Fax: (353-1) 863 2100
Web page: http://www.esri.ie
More information through EDIRC
References listed on IDEAS
Please report citation or reference errors to , or , if you are the registered author of the cited work, log in to your RePEc Author Service profile, click on "citations" and make appropriate adjustments.:
- Frank Windmeijer & Eric de Laat & Rudy Douven & Esther Mot, 2006.
"Pharmaceutical promotion and GP prescription behaviour,"
John Wiley & Sons, Ltd., vol. 15(1), pages 5-18.
- Eric de Laat & Rudy Douven & Esther Mot & F. Windmeijer, 2004. "Pharmaceutical promotion and GP prescription behaviour," CPB Discussion Paper 30, CPB Netherlands Bureau for Economic Policy Analysis.
- Honohan, Patrick & Donovan, Donal & Gorecki, Paul & Mottiar, Rafique, 2010. "The Irish Banking Crisis: Regulatory and Financial Stability Policy," MPRA Paper 24896, University Library of Munich, Germany.
- Valérie Paris & Elizabeth Docteur, 2008. "Pharmaceutical Pricing and Reimbursement Policies in Germany," OECD Health Working Papers 39, OECD Publishing.
- Dalen Gag Morten & Furu Kai & Locatelli Marilena & Strom Steinar, 2009.
"Generic substitution. Micro evidence from register data in Norway,"
Department of Economics and Statistics Cognetti de Martiis. Working Papers
200901, University of Turin.
- Dag Dalen & Kari Furu & Marilena Locatelli & Steinar Strøm, 2011. "Generic substitution: micro evidence from register data in Norway," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 12(1), pages 49-59, February.
- Mark Dusheiko & Hugh Gravelle & Rowena Jacobs & Peter C Smith, .
"The Effect of Budgets on Doctor Behaviour: Evidence From A Natural Experiment,"
03/04, Department of Economics, University of York.
- Mark Dusheiko & Hugh Gravelle & Rowena Jacobs & Peter Smith, 2003. "The Effects of Budgets on Doctors Behaviour: Evidence from a Natural Experiment," The Centre for Market and Public Organisation 03/064, Department of Economics, University of Bristol, UK.
- Lambrelli, Dimitra & O'Donnell, Owen, 2011. "The impotence of price controls: Failed attempts to constrain pharmaceutical expenditures in Greece," Health Policy, Elsevier, vol. 101(2), pages 162-171, July.
- Paraponaris, A. & Verger, P. & Desquins, B. & Villani, P. & Bouvenot, G. & Rochaix, L. & Gourheux, J. C. & Moatti, J. P. AU -, 2004. "Delivering generics without regulatory incentives?: Empirical evidence from French general practitioners about willingness to prescribe international non-proprietary names," Health Policy, Elsevier, vol. 70(1), pages 23-32, October.
- Lundin, Douglas, 2000. "Moral hazard in physician prescription behavior," Journal of Health Economics, Elsevier, vol. 19(5), pages 639-662, September.
- Michael Barry & Lesley Tilson & Máirín Ryan, 2004. "Pricing and reimbursement of drugs in Ireland," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 5(2), pages 190-194, May.
- Paul Gorecki, 2011. "Do you believe in magic? Improving the quality of pharmacy services through restricting entry and aspirational contracts, the Irish experience," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 12(6), pages 521-531, December.
- Brick, Aoife & Nolan, Anne & O'Reilly, Jacqueline & Smith, Samantha, 2010. "Resource Allocation, Financing and Sustainability in the Health Sector," Papers RB2010/3/1, Economic and Social Research Institute (ESRI).
- Brick, Aoife & Nolan, Anne, 2010. "The Sustainability of Irish Health Expenditure," Papers BP2011/5, Economic and Social Research Institute (ESRI).
- Nicolas Bloom & John Van Reenen, 1998. "Regulating drug prices: where do we go from here?," Fiscal Studies, Institute for Fiscal Studies, vol. 19(3), pages 321-342, August.
- Panos Kanavos & Joan Costa-Font, 2005. "Pharmaceutical parallel trade in Europe: stakeholder and competition effects," Economic Policy, CEPR;CES;MSH, vol. 20(44), pages 751-798, October.
- repec:esr:chaptr:jacb201058 is not listed on IDEAS
- Delnoij, Diana & Brenner, Gerhard, 2000. "Importing budget systems from other countries: what can we learn from the German drug budget and the British GP fundholding?," Health Policy, Elsevier, vol. 52(3), pages 157-169, July.
- repec:spr:pharme:v:28:y:2010:i:4:p:307-322 is not listed on IDEAS
When requesting a correction, please mention this item's handle: RePEc:esr:resser:rs24. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Sarah Burns)
If references are entirely missing, you can add them using this form.